20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Disease Models, Animal in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (25.71) | 29.6817 |
| 2010's | 24 (68.57) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, Y; Hirata, T; Inatani, S; Kojima, N; Koretsune, H; Ohara, H; Takahashi, T | 1 |
| Babapoor-Farrokhran, S; Hu, K; Kannan, S; Koehler, RC; Kulikowicz, E; Robertson, CL; Shu, S; Spicer, D; Zhang, Z | 1 |
| Bar, A; Chlopicki, S; Enggaard, C; Hansen, PBL; Jasztal, A; Jensen, B; Kieronska-Rudek, A; Kij, A; Marczyk, B; Mateuszuk, L; Matyjaszczyk-Gwarda, K; Proniewski, B; Przyborowski, K; Tworzydlo, A; Walczak, M | 1 |
| Che, D; Chen, J; Hammock, BD; Huang, F; Huang, H; Liu, Y; Qiu, K; Wang, J; Wang, MH; Yang, X | 1 |
| Amaral, LM; Cunningham, MW; Faulkner, JL; LaMarca, B; Murphy, S; Plenty, NL; Wallace, K | 1 |
| Hu, G; Ito, O; Kohzuki, M; Miura, T; Muroya, Y; Ogawa, Y; Rong, R; Wang, W | 1 |
| Cheng, G; Li, J; Li, Y; Li, Z; Liu, Y; Lu, L; Teng, G; Zhan, M | 1 |
| Lombard, JH; Lukaszewicz, KM | 1 |
| Baker, RC; Chen, BB; Fan, F; Johnson, DA; Liu, H; Orozco, LD; Perkins, E; Roman, RJ | 1 |
| Csiszar, A; Deak, F; Gautam, T; Koller, A; Mitschelen, M; Sonntag, WE; Sosnowska, D; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z | 1 |
| Buharalioglu, CK; Falck, JR; Kacan, M; Korkmaz, B; Malik, KU; Manthati, VL; Sahan Firat, S; Sari, AN; Serin, MS; Tunctan, B; Unsal, D | 1 |
| Carretero, OA; D'Ambrosio, MA; Garvin, JL; Peterson, EL; Ren, Y | 1 |
| Falck, JR; Fan, F; Ge, Y; Liu, R; Murphy, SR; Roman, RJ; Williams, JM | 1 |
| Alkayed, NJ; Anderson, VC; Borkar, RN; Cetas, JS; Dogan, A; Fairbanks, SL; Liu, JJ; Martini, RP; Nelson, JW; Raskin, JS; Siler, DA; Wang, RK; Ward, JP; Zuloaga, KL | 1 |
| Carroll, MA; Chander, PN; Kang, Y; Stier, CT | 1 |
| Fan, F; Geurts, AM; Jacob, HJ; Murphy, SR; Pabbidi, MR; Roman, RJ | 1 |
| Armstrong, JS; Bhalala, US; Koehler, RC; Kulikowicz, E; Lee, JH; Martin, LJ; Wang, B; Yang, ZJ; Zhu, J | 1 |
| Bernstein, KE; Capdevila, JH; Dakarapu, R; Ding, Y; Falck, JR; Garcia, V; Gotlinger, K; Joseph, G; Schwartzman, ML; Shkolnik, B; Zhang, FF | 1 |
| Cecen, P; Dakarapu, R; Falck, JR; Guden, DS; Malik, KU; Sahan-Firat, S; Sari, AN; Senol, SP; Temiz, M; Tunctan, B | 1 |
| Amrein, K; Buki, A; Czeiter, E; Horvath, P; Ivic, I; Koller, A; Szarka, N; Toth, P | 1 |
| Avner, ED; Jia, G; Park, F; Roman, RJ; Sweeney, WE | 1 |
| Dunn, KM; Falck, J; Flasch, AK; Harder, DR; Renic, M; Roman, RJ | 1 |
| Harder, DR; Kawashima, N; Klaus, JA; Koehler, RC; Miyata, N; Omura, T; Onishi, M; Renic, M; Roman, RJ | 1 |
| Akbulut, T; Avner, ED; Birudaraju, S; Falck, JR; Jia, G; Mueller, B; Park, F; Roman, RJ; Sweeney, WE | 1 |
| Abboud, HE; Barnes, JL; Block, K; Eid, AA; Fagg, BM; Gorin, Y; Maalouf, R | 1 |
| Chen, F; Liu, H; Liu, X; Wang, L; Yang, X; Zhang, Y; Zhao, Y; Zheng, Z | 1 |
| Cai, Y | 1 |
| Falck, JR; Friesma, J; Kunert, MP; Lombard, JH | 1 |
| Fava, C; Melander, O; Montagnana, M | 1 |
| Eto, K; Marumo, T; Nabekura, J; Omura, T; Wake, H | 1 |
| Estes, AM; Fang, XR; Farjana, N; Jennings, BL; Khan, AI; Malik, KU; Sahan-Firat, S; Song, CY; Yaghini, FA | 1 |
| Burke, M; Murphy, S; Roman, RJ; Williams, JM | 1 |
| Cervenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kopkan, L; Kramer, HJ; Sporková, A; Varcabová, S | 1 |
| Baker, R; Davis, DD; Fan, F; Lima, R; Moulana, M; Reckelhoff, JF; Roman, RJ; Romero, DG; Ryan, MJ; Yanes, LL; Yuan, K; Zhang, H | 1 |
| Fan, F; Jacob, HJ; Lazar, J; Murphy, S; Roman, RJ; Schreck, C; Williams, JM | 1 |
2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Disease Models, Animal
| Article | Year |
|---|---|
Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.
Topics: Animals; Blood Pressure; Cerebral Arteries; Cytochrome P-450 CYP4A; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Muscle, Smooth, Vascular; Rats; Rats, Inbred BN; Rats, Inbred Dahl; Reactive Oxygen Species; Signal Transduction; Sodium Chloride, Dietary; Up-Regulation; Vasoconstriction | 2013 |
20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.
Topics: Animals; Antihypertensive Agents; Arachidonic Acid; Biological Transport; Blood Vessels; Disease Models, Animal; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Molecular Targeted Therapy; Sodium | 2010 |
33 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Disease Models, Animal
| Article | Year |
|---|---|
Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephritis; Renal Insufficiency, Chronic; Ureteral Obstruction | 2023 |
Administration of a 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor Improves Outcome in a Rat Model of Pediatric Traumatic Brain Injury.
Topics: Amidines; Animals; Brain; Brain Injuries, Traumatic; Cytokines; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Inflammation; Male; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice.
Topics: Angiotensin II; Animals; Antithrombins; Chromatography, Liquid; Dabigatran; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Intercellular Adhesion Molecule-1; Male; Mice; Nitric Oxide; Tandem Mass Spectrometry; Vascular Remodeling; von Willebrand Factor | 2021 |
Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
Topics: Amidines; Angiogenesis Inducing Agents; Animals; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Drugs, Chinese Herbal; Endothelial Progenitor Cells; Hydroxyeicosatetraenoic Acids; Male; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A | 2017 |
Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia.
Topics: Amidines; Animals; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Models, Animal; Female; Hydroxyeicosatetraenoic Acids; Pre-Eclampsia; Pregnancy; Rats | 2018 |
Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor.
Topics: Angiotensin II; Animals; Arachidonic Acid; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cytochrome P-450 CYP4A; Disease Models, Animal; Gene Expression Regulation; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Protein Isoforms; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2018 |
Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Topics: Angiogenesis Inducing Agents; Animals; Astrocytes; Brain Ischemia; Cell Proliferation; Cytochrome P-450 CYP4A; Disease Models, Animal; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Microcirculation; Neovascularization, Pathologic; Stroke; Vascular Endothelial Growth Factor A | 2019 |
20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
Topics: Amidines; Angioplasty, Balloon, Coronary; Animals; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Movement; Cell Proliferation; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hyperplasia; Male; Muscle, Smooth, Vascular; Neointima; Rats; Rats, Sprague-Dawley; Triazoles; Tunica Intima | 2013 |
Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension.
Topics: Actins; Adaptation, Physiological; Aging; Angiotensin II; Animals; Behavior, Animal; Blood-Brain Barrier; Cerebrovascular Circulation; Cytokines; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microvessels; Middle Cerebral Artery; TRPC Cation Channels; TRPC6 Cation Channel; Up-Regulation | 2013 |
Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKKβ/IκB-α/NF-κB pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock.
Topics: Animals; Aorta, Thoracic; Arterial Pressure; Disease Models, Animal; Heart Rate; Hydroxyeicosatetraenoic Acids; I-kappa B Kinase; I-kappa B Proteins; Kidney; Lipopeptides; Lipopolysaccharides; Male; MAP Kinase Kinase Kinases; Mesenteric Artery, Superior; MicroRNAs; Myeloid Differentiation Factor 88; Myocardium; Protective Agents; Rats, Wistar; Shock, Septic; Transcription Factor RelA | 2014 |
Mechanism of impaired afferent arteriole myogenic response in Dahl salt-sensitive rats: role of 20-HETE.
Topics: Adenosine Triphosphate; Afferent Pathways; Animals; Arterioles; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Microvessels; Muscle Development; Norepinephrine; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Vasoconstriction | 2014 |
Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats.
Topics: Adenosine; Afferent Pathways; Animals; Arachidonic Acid; Arterioles; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Microvessels; Muscle Development; Rats; Rats, Inbred BN; Rats, Inbred Dahl; Rats, Sprague-Dawley; Regional Blood Flow; Transforming Growth Factors; Vasoconstriction | 2014 |
Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage.
Topics: 8,11,14-Eicosatrienoic Acid; Aged; Animals; Brain Ischemia; Disease Models, Animal; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Mice; Middle Aged; Neuroprotective Agents; Subarachnoid Hemorrhage | 2015 |
Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels.
Topics: Angiotensin I; Animals; Benzimidazoles; Blood Pressure; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Hypertension, Renovascular; Male; Oxadiazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2015 |
Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat.
Topics: Animals; Arterial Pressure; Blood-Brain Barrier; Capillary Permeability; Cerebrovascular Circulation; Cytochrome P-450 CYP4A; Disease Models, Animal; Genotype; Homeostasis; Hydroxyeicosatetraenoic Acids; Hypertension; Middle Cerebral Artery; Phenotype; Rats, Inbred Dahl; Rats, Inbred Lew; Rats, Transgenic; Sodium Chloride, Dietary; Transposases; Vascular Remodeling; Vasoconstriction | 2015 |
Additive Neuroprotection of a 20-HETE Inhibitor with Delayed Therapeutic Hypothermia after Hypoxia-Ischemia in Neonatal Piglets.
Topics: Amidines; Animals; Animals, Newborn; Cytochrome P-450 CYP4A; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Swine | 2015 |
Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Transgenic; Microvessels; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Time Factors; Vascular Remodeling | 2015 |
Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock.
Topics: alpha Karyopherins; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypotension; Kidney; Lipopeptides; Lipopolysaccharides; Male; Mesenteric Arteries; Myocardium; PPAR alpha; PPAR gamma; PPAR-beta; Rats, Wistar; Retinoid X Receptor alpha; Shock, Septic; Tachycardia; Transcription Factor AP-1 | 2016 |
Hypertension-Induced Enhanced Myogenic Constriction of Cerebral Arteries Is Preserved after Traumatic Brain Injury.
Topics: Animals; Brain Injuries, Diffuse; Brain Injuries, Traumatic; Cerebrovascular Circulation; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Middle Cerebral Artery; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2017 |
20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease.
Topics: Amidines; Animals; Cell Culture Techniques; Cell Proliferation; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; Epithelial Cells; Hydroxyeicosatetraenoic Acids; Mice; Mice, Inbred BALB C; Polycystic Kidney Diseases | 2008 |
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Topics: Amidines; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Infarction, Middle Cerebral Artery; Isoenzymes; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Up-Regulation | 2008 |
Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion.
Topics: Animals; Brain; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Disease Models, Animal; Formamides; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mass Spectrometry; Morpholines; Neuroprotective Agents; Rats; Rats, Wistar | 2009 |
Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Cyclic AMP; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Activation; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Organ Size; Polycystic Kidney, Autosomal Recessive; Protein Isoforms; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2009 |
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.
Topics: Animals; Cytochrome P-450 CYP4A; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Glucose; Hydroxyeicosatetraenoic Acids; Mice; Mice, Mutant Strains; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Podocytes; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.
Topics: Animals; Base Sequence; Blood Pressure; Cell Line; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; DNA, Complementary; Gene Expression; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney Tubules, Proximal; Mice; Mice, Transgenic; Promoter Regions, Genetic; Recombinant Proteins; Transfection | 2009 |
Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model??
Topics: Animals; Blood Pressure; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; Gene Expression; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Mice; Mice, Transgenic; Models, Cardiovascular; Recombinant Proteins | 2009 |
CYP450 4A inhibition attenuates O2 induced arteriolar constriction in chronic but not acute Goldblatt hypertension.
Topics: Amides; Animals; Arterioles; Chronic Disease; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Male; Muscle, Skeletal; Nephrectomy; Oxygen; Rats; Rats, Sprague-Dawley; Sulfones; Vasoconstriction | 2009 |
Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.
Topics: Animals; Blood Pressure; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Mice; Mice, Transgenic; Species Specificity; Up-Regulation | 2009 |
The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice.
Topics: Animals; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Formamides; Homeostasis; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Microcirculation; Morpholines | 2010 |
2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Antihypertensive Agents; Aorta; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Cardiomegaly; Cytochrome P-450 CYP1B1; Desoxycorticosterone; Disease Models, Animal; Diuresis; Endothelium, Vascular; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; p38 Mitogen-Activated Protein Kinases; Proteinuria; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Stilbenes; Superoxides; Time Factors; Vasoconstriction; Vasodilation | 2010 |
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.
Topics: Amidines; Animals; Arachidonic Acids; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Kidney; Male; Rats; Regional Blood Flow; Sodium | 2011 |
Postmenopausal hypertension: role of 20-HETE.
Topics: Aging; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Disease Models, Animal; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Postmenopause; Rats; Rats, Inbred SHR; Triazoles | 2011 |
Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats.
Topics: Animals; Blood Pressure; Cytochrome P-450 CYP4A; Disease Models, Animal; Genetic Therapy; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Rats; Rats, Inbred BN; Rats, Inbred Dahl; RNA, Messenger; Time Factors | 2012 |